Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy.

<h4>Background</h4>Treatment options for many cancers include immune checkpoint inhibitor (ICI) monotherapy and combination therapy with impressive clinical benefit across cancers. We sought to define the comparative cardiac risks of ICI combination and monotherapy.<h4>Methods</...

Full description

Bibliographic Details
Main Authors:	Eugene B Cone, Lorine Haeuser, Stephen W Reese, Maya Marchese, David-Dan Nguyen, Junaid Nabi, Wesley H Chou, Joachim Noldus, Rana R McKay, Kerry Laing Kilbridge, Quoc-Dien Trinh
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0272022

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy by Eugene B. Cone, Lorine Haeuser, Stephen W. Reese, Maya Marchese, David-Dan Nguyen, Junaid Nabi, Wesley H. Chou, Joachim Noldus, Rana R. McKay, Kerry Laing Kilbridge, Quoc-Dien Trinh

Published 2022-01-01

Get full text

Article

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy.

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy by Eugene B. Cone, Lorine Haeuser, Stephen W. Reese, Maya Marchese, David-Dan Nguyen, Junaid Nabi, Wesley H. Chou, Joachim Noldus, Rana R. McKay, Kerry Laing Kilbridge, Quoc-Dien Trinh

Similar Items